From bioinks to bioprinters
We offer premium bioinks, bioprinters and services that enable critical breakthroughs in 3D cell culturing, tissue engineering and drug development.
By releasing the first universal bioink in 2016, we democratized the cost of entry for researchers around the world and played a major role in turning the then up-and-coming field of 3D bioprinting into the thriving $1 billion industry it is today.
Our best-in-class bioinks, bioprinters, software and services are being used by the foremost academics and R&D labs and have enabled critical breakthroughs in a wide range of applications from 3D cell culturing to tissue engineering to drug development.
CELLINK is dedicated to taking the on-demand biofabrication of human organs and tissues to the next level, in line with BICO’s vision to leverage bioconvergence in the life sciences and create the future of health.
We leverage the talents and enthusiasm of more than 180 engineers, scientists, financial experts and sales and marketing specialists to nurture the research and development of innovative life-science products and technologies for a wide range of applications and industries.
Transforming ideas into revolutionary products
We are growing!
A BICO company
CELLINK is proud to be a part of BICO, the world’s leading bioconvergence company, which leverages the synergies of its premier companies in engineering, robotics, artificial intelligence, advanced genomics and bioprinting to create the future of health.
BICO envisions a future that ensures bioprinted organ transplants are obtainable, cultivated human tissues replace animal testing, every patient can get personalized medicine, drug development is faster and less expensive, easy-to-access diagnostics prevent pandemics.